Presentations & Publications

Publication

Neoantigens that fail to elicit measurable T cell responses following peptide immunization can control tumor growth when delivered using a Listeria-based immunotherapy platform

AACR 2018

STAY TUNED

Mailing List

Sign up for email alerts for Press Releases & breaking Advaxis news.

SOCIAL

Follow Us

Stay up to date on the latest events, news, and happenings on Advaxis and Immunotherapy.